Edition:
United States

UDG Healthcare PLC (UDG.L)

UDG.L on London Stock Exchange

885.00GBp
15 Dec 2017
Change (% chg)

4.50 (+0.51%)
Prev Close
880.50
Open
877.50
Day's High
886.00
Day's Low
875.50
Volume
1,061,767
Avg. Vol
656,821
52-wk High
963.00
52-wk Low
632.50

Chart for

About

UDG Healthcare PLC, formerly United Drug PLC, provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 24 countries and delivering services in over 50 countries. The Company operates across three divisions: Ashfield, which provides commercializatio... (more)
No analyst recommendations are available for .

Overall

Beta: 0.81
Market Cap(Mil.): €2,506.15
Shares Outstanding(Mil.): 248.33
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 28.82 16.04
EPS (TTM): -- -- --
ROI: -- 7.96 34.69
ROE: -- 11.65 15.46

UPDATE 1-UDG Healthcare CFO to retire; profit jumps 17 pct

Nov 28 UDG Healthcare reported a 17 percent increase in full-year earnings on Tuesday, driven mainly by acquisitions, and said Chief Financial Officer Alan Ralph would retire by the end of 2018.

Nov 28 2017

REFILE-UDG Healthcare profit jumps 17 pct; CFO to step down

Nov 28 UDG Healthcare reported a 17 percent increase in full-year earnings on Tuesday, driven mainly by acquisitions, and said Chief Financial Officer Alan Ralph would step down.

Nov 28 2017

BRIEF-UDG Healthcare ‍announces acquisition of US-based healthcare communications agency​

* ‍ANNOUNCES ACQUISITION OF US-BASED HEALTHCARE COMMUNICATIONS AGENCY FOR UP TO $75.8M​

Sep 14 2017

BRIEF-UDG Healthcare acquires Cambridge Biomarketing

* Says acquisition of Cambridge Biomarketing LLC, a US-based healthcare communications business, for a total consideration of up to $35 mln

Jul 17 2017

BRIEF-UDG Healthcare ‍acquires Vynamic for up to $32 mln

* ‍Acquisition of Vynamic Llc, a US-based healthcare industry management consulting firm, for total consideration of up to $32 million​

Jul 12 2017

Earnings vs. Estimates

No consensus analysis data available.